Literature DB >> 6096062

Axial apraxia, a distinct phenomenon.

J P Lakke, T W van Weerden, A Staal-Schreinemachers.   

Abstract

Three Parkinson patients who continued to have difficulties with turning in the horizontal plane despite adequate and therapeutically effective levodopa treatment are presented. The handicap of the disordered axial rotation, to be considered an elementary displacement of the body, could be alleviated by alternative motor strategies or overcome by specific extra stimuli or tactile guidance but not physiotherapeutically restored. On the basis of these clinical observations it is argued that these axial movement abnormalities are apraxic.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096062     DOI: 10.1016/0303-8467(84)90291-9

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Axial rotation in Parkinson's disease.

Authors:  M Vaugoyeau; F Viallet; R Aurenty; C Assaiante; S Mesure; J Massion
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

2.  Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study.

Authors:  D Guehl; P Dehail; M P de Sèze; E Cuny; P Faux; F Tison; M Barat; B Bioulac; P Burbaud
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

3.  Reaching to ipsilateral or contralateral targets: within-hemisphere visuomotor processing cannot explain hemispatial differences in motor control.

Authors:  D P Carey; E L Hargreaves; M A Goodale
Journal:  Exp Brain Res       Date:  1996-12       Impact factor: 1.972

4.  Disordered axial movement in Parkinson's disease.

Authors:  M J Steiger; P D Thompson; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

5.  Deep brain stimulation amplitude alters posture shift velocity in Parkinson's disease.

Authors:  Narayanan Krishnamurthi; Stefani Mulligan; Padma Mahant; Johan Samanta; James J Abbas
Journal:  Cogn Neurodyn       Date:  2012-04-12       Impact factor: 5.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.